resistanceBio has filed a notice of an exempt offering of securities to raise $12,776,288.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, resistanceBio is raising up to $12,776,288.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kyle Lapham played a key…